posted on 2013-11-05, 00:00authored byDa Huang, Tao Zhao, Wei Xu, Tinglu Yang, Paul S. Cremer
Herein,
we utilized a label-free sensing platform based on pH modulation
to detect the interactions between tetracaine, a positively charged
small molecule used as a local anesthetic, and planar supported lipid
bilayers (SLBs). The SLBs were patterned inside a flow cell, allowing
for various concentrations of tetracaine to be introduced over the
surface in a buffer solution. Studies with membranes containing POPC
(1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine)
yielded an equilibrium dissociation constant value of Kd = 180 ± 47 μm for this small molecule–membrane
interaction. Adding cholesterol to the SLBs decreased the affinity
between tetracaine and the bilayers, while this interaction tightened
when POPE (1-hexadecanoyl-2-(9-Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine) was added. Studies
were also conducted with three negatively charged membrane lipids,
POPG (1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt)), POPS (1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-l-serine (sodium salt)), and
ganglioside GM1. All three measurements gave rise to a similar tightening
of the apparent Kd value compared with
pure POPC membranes. The lack of chemical specificity with the identity
of the negatively charged lipid indicated that the tightening was
largely electrostatic. Through a direct comparison with ITC measurements,
it was found that the pH modulation sensor platform offers a facile,
inexpensive, highly sensitive, and rapid method for the detection
of interactions between putative drug candidates and lipid bilayers.
As such, this technique may potentially be exploited as a screen for
drug development and analysis.